CARDIAC RSK3 INHIBITORS, LLC
Los Altos, United States · Founded 2019
- Headquarters
- Los Altos, California
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
About
Cardiac RSK3 Inhibitors LLC is an early-stage biopharmaceutical company developing novel biologic drugs for heart failure by targeting RSK3, a kinase that regulates pathological cardiac remodeling. Founded by Dr. Michael Kapiloff, the company is advancing an adeno-associated virus (AAV) gene therapy vector expressing an RSK3 anchoring disruptor peptide that blocks the mAKAP-RSK3 signaling complex implicated in heart failure progression.
Summary
CARDIAC RSK3 INHIBITORS, LLC is a Biotech company based in Los Altos, United States, founded in 2019.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cardiac-rsk3-inhibitors-llc"><img src="https://indexed.vc/api/badge/company/cardiac-rsk3-inhibitors-llc" alt="CARDIAC RSK3 INHIBITORS, LLC on Indexed.vc" width="260" height="76" /></a>